BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yunusova NV, Kondakova IV, Kolomiets LA, Afanas'ev SG, Chernyshova AL, Kudryavtsev IV, Tsydenova AA. Molecular targets for the therapy of cancer associated with metabolic syndrome (transcription and growth factors). Asia Pac J Clin Oncol 2018;14:134-40. [PMID: 29115033 DOI: 10.1111/ajco.12780] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Hu D, Zhang M, Zhang H, Xia Y, Lin J, Zheng X, Peng F, Niu W. Prediction of Metabolic Syndrome for the Survival of Patients With Digestive Tract Cancer: A Meta-Analysis. Front Oncol 2019;9:281. [PMID: 31058084 DOI: 10.3389/fonc.2019.00281] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
2 Dong S, Wang Z, Shen K, Chen X. Metabolic Syndrome and Breast Cancer: Prevalence, Treatment Response, and Prognosis. Front Oncol 2021;11:629666. [PMID: 33842335 DOI: 10.3389/fonc.2021.629666] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Tugutova EA, Tamkovich SN, Patysheva MR, Afanas’ev SG, Tsydenova AA, Grigor’eva AE, Kolegova ES, Kondakova IV, Yunusova NV. Relation between Tetraspanin- Associated and Tetraspanin- Non- Associated Exosomal Proteases and Metabolic Syndrome in Colorectal Cancer Patients. Asian Pac J Cancer Prev 2019;20:809-15. [PMID: 30909692 DOI: 10.31557/APJCP.2019.20.3.809] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
4 González-González A, Mediavilla MD, Sánchez-Barceló EJ. Melatonin: A Molecule for Reducing Breast Cancer Risk. Molecules 2018;23:E336. [PMID: 29415446 DOI: 10.3390/molecules23020336] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]